SG11201506446YA - Tert promoter mutations in gliomas and a subset of tumors - Google Patents

Tert promoter mutations in gliomas and a subset of tumors

Info

Publication number
SG11201506446YA
SG11201506446YA SG11201506446YA SG11201506446YA SG11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA SG 11201506446Y A SG11201506446Y A SG 11201506446YA
Authority
SG
Singapore
Prior art keywords
gliomas
tumors
subset
tert promoter
promoter mutations
Prior art date
Application number
SG11201506446YA
Other languages
English (en)
Inventor
Yan Hai
Vogelstein Bert
Papadopoulos Nikolas
W Kinzler Kenneth
Jiao Yuchen
Bettegowda Chetan
D Bigner Darell
Original Assignee
Univ Duke
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51354619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201506446Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Duke, Univ Johns Hopkins filed Critical Univ Duke
Publication of SG11201506446YA publication Critical patent/SG11201506446YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201506446YA 2013-02-18 2014-02-18 Tert promoter mutations in gliomas and a subset of tumors SG11201506446YA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361765909P 2013-02-18 2013-02-18
US201361766857P 2013-02-20 2013-02-20
US201361772249P 2013-03-04 2013-03-04
PCT/US2014/016906 WO2014127359A1 (fr) 2013-02-18 2014-02-18 Mutations du promoteur de tert dans les gliomes et un sous-ensemble de tumeurs

Publications (1)

Publication Number Publication Date
SG11201506446YA true SG11201506446YA (en) 2015-09-29

Family

ID=51354619

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201506446YA SG11201506446YA (en) 2013-02-18 2014-02-18 Tert promoter mutations in gliomas and a subset of tumors

Country Status (7)

Country Link
US (1) US10711310B2 (fr)
EP (2) EP2956556B1 (fr)
JP (3) JP6574385B2 (fr)
KR (1) KR101832948B1 (fr)
CN (1) CN105683391A (fr)
SG (1) SG11201506446YA (fr)
WO (1) WO2014127359A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
US10711310B2 (en) 2013-02-18 2020-07-14 Duke University Tert promoter mutations in gliomas and a subset of tumors
CN104805206B (zh) * 2015-04-29 2017-06-20 苏州工业园区为真生物医药科技有限公司 检测tert基因启动子突变的试剂盒及其检测方法
EP3322824A4 (fr) * 2015-07-14 2019-01-23 The Johns Hopkins University Détection d'adn dérivé de tumeurs dans le liquide céphalorachidien
CN105695596A (zh) * 2016-03-22 2016-06-22 南京艾迪康医学检验所有限公司 检测tert基因启动子c250t、c228t突变位点的方法、引物和试剂盒
JP7072825B2 (ja) * 2017-09-13 2022-05-23 三菱電機ソフトウエア株式会社 コピー数計測装置、コピー数計測プログラムおよびコピー数計測方法
CN107541557A (zh) * 2017-09-27 2018-01-05 迈基诺（重庆）基因科技有限责任公司 一种检测人类tert基因启动子热点突变的荧光定量pcr方法及其用途
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
AU2020247911A1 (en) 2019-03-26 2021-11-11 Dermtech, Inc. Novel gene classifiers and uses thereof in skin cancers
KR102203850B1 (ko) * 2019-04-09 2021-01-18 사회복지법인 삼성생명공익재단 신경교종의 진단 또는 예후 예측용 조성물 및 이에 관한 정보를 제공하는 방법
KR20210026616A (ko) * 2019-08-30 2021-03-10 지니너스 주식회사 텔로머라제 역전사 효소의 변이 검출용 pcr 프라이머 조성물 및 이의 용도
KR20220068581A (ko) * 2020-11-19 2022-05-26 (주)큐리진 암세포 특이적 유전자 발현을 조절하는 변형된 hTERT 프로모터 및 이를 포함하는 항종양 아데노바이러스

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
HUP0004134A2 (en) * 1997-10-21 2001-03-28 Cancer Res Campaign Tech Determination of cellular growth abnormality
EP1394268A1 (fr) 2002-08-16 2004-03-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) HNF1alpha en tant que suppresseur de tumeur et utilisation thérapeutiques et diagnostiques de celle-ci
US20060088850A1 (en) * 2004-05-28 2006-04-27 Fred Hutchinson Cancer Research Center Method for genome-wide analysis of palindrome formation and uses thereof
US10711310B2 (en) 2013-02-18 2020-07-14 Duke University Tert promoter mutations in gliomas and a subset of tumors

Also Published As

Publication number Publication date
EP2956556B1 (fr) 2019-04-10
KR101832948B1 (ko) 2018-02-28
JP2021078521A (ja) 2021-05-27
US10711310B2 (en) 2020-07-14
EP2956556A4 (fr) 2016-10-12
JP2018050621A (ja) 2018-04-05
JP7191140B2 (ja) 2022-12-16
EP3360979B1 (fr) 2020-05-20
JP6574385B2 (ja) 2019-09-11
WO2014127359A1 (fr) 2014-08-21
EP2956556A1 (fr) 2015-12-23
EP3360979A1 (fr) 2018-08-15
US20150361507A1 (en) 2015-12-17
CN105683391A (zh) 2016-06-15
KR20150132181A (ko) 2015-11-25
JP2016506760A (ja) 2016-03-07

Similar Documents

Publication Publication Date Title
SG11201506446YA (en) Tert promoter mutations in gliomas and a subset of tumors
IL263026A (en) Combination therapy containing ibrutinib
HK1254296A1 (zh) 治療性化合物和其用途
EP3412222C0 (fr) Agrafeuse chirurgicale avec poches partielles
GB201322725D0 (en) Cancer therapy
HK1221721A1 (zh) 蛋白抑制性的改性的二氫喹喔啉酮類化合物和二氫吡啶並吡嗪酮類化合物
HK1217092A1 (zh) 治療性化合物及其用途
EP2968345A4 (fr) Inhibiteurs doubles de mek/pi3k et procédés thérapeutiques les utilisant
IL246280B (en) Therapeutic methods and preparations
HK1220900A1 (zh) 癌症的治療
SG11201507847UA (en) Cancer therapy
ZA201607581B (en) Dosage forms and therapeutic uses l-4lchlorokynurenine
EP2984184A4 (fr) Polythérapie pour tumeur sélective
GB2515865B (en) Use of galactooligosaccharides in therapy
EP2961412A4 (fr) Cancérothérapie
EP2978521A4 (fr) Plaque de base inclinée pour réacteur de déshydrogénation
IL241768B (en) 2beta, 3alpha, 5alpha-trihydroxy-androstane-6-one, methods for its preparation and uses
GB201308753D0 (en) Compounds and their use in therapy
GB201518731D0 (en) Tumour Therapy
GB201309498D0 (en) Novel diagnosis and therapy
GB201308365D0 (en) Tumour therapy
GB201321504D0 (en) Novel analgesic therapy
GB201202945D0 (en) Novel cancer therapies and methods
GB201313895D0 (en) Novel analgesic therapy
EP2996684A4 (fr) Méthodes thérapeutiques